Pulmozyme® (dornase alfa)
for Cystic Fibrosis

Pulmozyme (dornase alfa) is a synthetic enzyme used to treat cystic fibrosis by breaking down excess DNA in pulmonary secretions, helping to thin mucus in the airways. This improves lung function and reduces the risk of infections. Administered via nebulizer, Pulmozyme works by decreasing the thickness and stickiness of mucus, making it easier to clear from the lungs.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Cystic Fibrosis - CF